These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 3007103)
1. Relationship of silica and bacillus Calmette-Guerin exposures to humoral and cellular immune functions. Zarkower A; Eskew ML; Scheuchenzuber WJ Environ Res; 1986 Apr; 39(2):278-89. PubMed ID: 3007103 [TBL] [Abstract][Full Text] [Related]
2. Mucosal immunization with recombinant heparin-binding haemagglutinin adhesin suppresses extrapulmonary dissemination of Mycobacterium bovis bacillus Calmette-Guérin (BCG) in infected mice. Kohama H; Umemura M; Okamoto Y; Yahagi A; Goga H; Harakuni T; Matsuzaki G; Arakawa T Vaccine; 2008 Feb; 26(7):924-32. PubMed ID: 18192091 [TBL] [Abstract][Full Text] [Related]
3. A single strain of Mycobacterium bovis bacillus Calmette-Guérin (BCG) grown in two different media evokes distinct humoral immune responses in mice. Petricevich VL; Ueda C; Alves RC; da Silva MA; Moreno C; Melo AR; Dias da Silva W Braz J Med Biol Res; 2001 Jan; 34(1):81-92. PubMed ID: 11151032 [TBL] [Abstract][Full Text] [Related]
4. Effect of a single exposure to ultraviolet radiation on Mycobacterium bovis bacillus Calmette-Guerin infection in mice. Jeevan A; Kripke ML J Immunol; 1989 Nov; 143(9):2837-43. PubMed ID: 2681417 [TBL] [Abstract][Full Text] [Related]
5. Protective effect of beta-glucan against mycobacterium bovis, BCG infection in BALB/c mice. Hetland G; Løvik M; Wiker HG Scand J Immunol; 1998 Jun; 47(6):548-53. PubMed ID: 9652822 [TBL] [Abstract][Full Text] [Related]
6. Influence of immunisation with Mycobacterium bovis bacillus Calmette-Guérin on the sensitisation to inhaled allergens after infection with respiratory syncytial virus. Vonberg RP; Mueller M; Emmendoerffer A; Freihorst J Clin Exp Med; 2005 Dec; 5(4):177-83. PubMed ID: 16362797 [TBL] [Abstract][Full Text] [Related]
7. The influence of remaining live BCG organisms in vaccinated mice on the maintenance of immunity to tuberculosis. Olsen AW; Brandt L; Agger EM; van Pinxteren LA; Andersen P Scand J Immunol; 2004 Sep; 60(3):273-7. PubMed ID: 15320884 [TBL] [Abstract][Full Text] [Related]
8. Strain differences in mouse cellular responses to Mycobacterium lepraemurium and BCG subcutaneous infections. II. Production of interleukins 2, 4, and 6 and of interferon-gamma by draining lymph node cells. Roch F; Bach MA Clin Immunol Immunopathol; 1991 Sep; 60(3):443-54. PubMed ID: 1907533 [TBL] [Abstract][Full Text] [Related]
9. Transmembrane TNF induces an efficient cell-mediated immunity and resistance to Mycobacterium bovis bacillus Calmette-Guérin infection in the absence of secreted TNF and lymphotoxin-alpha. Olleros ML; Guler R; Corazza N; Vesin D; Eugster HP; Marchal G; Chavarot P; Mueller C; Garcia I J Immunol; 2002 Apr; 168(7):3394-401. PubMed ID: 11907097 [TBL] [Abstract][Full Text] [Related]
11. Heat-Shock Protein gp96 Enhances T Cell Responses and Protective Potential to Bacillus Calmette-Guérin Vaccine. Ding Y; Zheng H; Feng C; Wang B; Liu C; Mi K; Cao H; Meng S Scand J Immunol; 2016 Oct; 84(4):222-8. PubMed ID: 27417661 [TBL] [Abstract][Full Text] [Related]
12. Lactoferrin augments BCG vaccine efficacy to generate T helper response and subsequent protection against challenge with virulent Mycobacterium tuberculosis. Hwang SA; Kruzel ML; Actor JK Int Immunopharmacol; 2005 Mar; 5(3):591-9. PubMed ID: 15683854 [TBL] [Abstract][Full Text] [Related]
13. Mice that overexpress CC chemokine ligand 2 in their lungs show increased protective immunity to infection with Mycobacterium bovis bacille Calmette-Guérin. Schreiber O; Steinwede K; Ding N; Srivastava M; Maus R; Länger F; Prokein J; Ehlers S; Welte T; Gunn MD; Maus UA J Infect Dis; 2008 Oct; 198(7):1044-54. PubMed ID: 18694332 [TBL] [Abstract][Full Text] [Related]
14. Behavior of attenuated mycobacteria in organs of neonatal and adult mice. Costello RT; Izumi T; Sakurami T J Exp Med; 1971 Aug; 134(2):366-80. PubMed ID: 4934501 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of Immunogenicity and Protective Efficacy Elicited by Mycobacterium bovis BCG Overexpressing Ag85A Protein against Mycobacterium tuberculosis Aerosol Infection. Xu ZZ; Chen X; Hu T; Meng C; Wang XB; Rao Y; Zhang XM; Yin YL; Pan ZM; Jiao XA Front Cell Infect Microbiol; 2016; 6():3. PubMed ID: 26858942 [TBL] [Abstract][Full Text] [Related]
16. DNA vaccination using bacillus Calmette-Guerin-DNA as an adjuvant to enhance immune response to three kinds of swine diseases. Zhang S; Guo YJ; Sun SH; Wang KY; Wang KH; Zhang Y; Zhu WJ; Chen ZH; Jiang L Scand J Immunol; 2005 Oct; 62(4):371-7. PubMed ID: 16253124 [TBL] [Abstract][Full Text] [Related]
17. Oral delivery of lipid-encapsulated Mycobacterium bovis BCG extends survival of the bacillus in vivo and induces a long-term protective immune response against tuberculosis. Aldwell FE; Cross ML; Fitzpatrick CE; Lambeth MR; de Lisle GW; Buddle BM Vaccine; 2006 Mar; 24(12):2071-8. PubMed ID: 16332403 [TBL] [Abstract][Full Text] [Related]
19. Loss of anti-mycobacterial efficacy in mice over time following vaccination with Mycobacterium bovis bacillus Calmette-Guérin. Ozeki Y; Hirayama Y; Takii T; Yamamoto S; Kobayashi K; Matsumoto S Vaccine; 2011 Sep; 29(40):6881-7. PubMed ID: 21803102 [TBL] [Abstract][Full Text] [Related]